General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL

Claudia Fazi, Lydia Scarfò, Lorenza Pecciarini, Francesca Cottini, Antonis Dagklis, Agnieszka Janus, Anna Talarico, Cristina Scielzo, Cinzia Sala, Daniela Toniolo, Federico Caligaris-Cappio, Paolo Ghia

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

Monoclonal B-cell lymphocytosis (MBL) is classified as chronic lymphocytic leukemia (CLL)-like, atypical CLL, and CD5 -MBL. The number of B cells per microliter divides CLL-like MBL into MBL associated with lymphocytosis (usually detected in a clinical setting) and low-count MBL detected in the general population (usually identified during population screening). After a median follow-up of 34 months we reevaluated 76 low-count MBLs with 5-color flow cytometry: 90% of CLL-like MBL but only 44.4% atypical CLL and 66.7% CD5 - MBL persisted over time. Population-screening CLL-like MBL had no relevant cell count change, and none developed an overt leukemia. In 50% of the cases FISH showed CLL-related chromosomal abnormalities, including monoallelic or biallelic 13q deletions (43.8%), trisomy 12 (1 case), and 17p deletions (2 cases). The analysis of the T-cell receptor β (TRBV) chains repertoire showed the presence of monoclonal T-cell clones, especially among CD4 highCD8 low, CD8 highCD4 low T cells. TRBV2 and TRBV8 were the most frequently expressed genes. This study indicates that (1) the risk of progression into CLL for low-count population-screening CLL-like MBL is exceedingly rare and definitely lower than that of clinical MBL and (2) chromosomal abnormalities occur early in the natural history and are possibly associated with the appearance of the typical phenotype.

Original languageEnglish
Pages (from-to)6618-6625
Number of pages8
JournalBlood
Volume118
Issue number25
DOIs
Publication statusPublished - Dec 15 2011

Fingerprint

Lymphocytosis
B-Cell Chronic Lymphocytic Leukemia
Chromosome Aberrations
Screening
B-Lymphocytes
T-cells
Cells
Population
Flow cytometry
T-Cell Antigen Receptor
Genes
Color
T-Lymphocytes
Trisomy
Natural History
Flow Cytometry
Leukemia
Clone Cells
Cell Count

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. / Fazi, Claudia; Scarfò, Lydia; Pecciarini, Lorenza; Cottini, Francesca; Dagklis, Antonis; Janus, Agnieszka; Talarico, Anna; Scielzo, Cristina; Sala, Cinzia; Toniolo, Daniela; Caligaris-Cappio, Federico; Ghia, Paolo.

In: Blood, Vol. 118, No. 25, 15.12.2011, p. 6618-6625.

Research output: Contribution to journalArticle

Fazi, C, Scarfò, L, Pecciarini, L, Cottini, F, Dagklis, A, Janus, A, Talarico, A, Scielzo, C, Sala, C, Toniolo, D, Caligaris-Cappio, F & Ghia, P 2011, 'General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL', Blood, vol. 118, no. 25, pp. 6618-6625. https://doi.org/10.1182/blood-2011-05-357251
Fazi, Claudia ; Scarfò, Lydia ; Pecciarini, Lorenza ; Cottini, Francesca ; Dagklis, Antonis ; Janus, Agnieszka ; Talarico, Anna ; Scielzo, Cristina ; Sala, Cinzia ; Toniolo, Daniela ; Caligaris-Cappio, Federico ; Ghia, Paolo. / General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. In: Blood. 2011 ; Vol. 118, No. 25. pp. 6618-6625.
@article{b02d1a8d97754fa28883887c159ef8ea,
title = "General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL",
abstract = "Monoclonal B-cell lymphocytosis (MBL) is classified as chronic lymphocytic leukemia (CLL)-like, atypical CLL, and CD5 -MBL. The number of B cells per microliter divides CLL-like MBL into MBL associated with lymphocytosis (usually detected in a clinical setting) and low-count MBL detected in the general population (usually identified during population screening). After a median follow-up of 34 months we reevaluated 76 low-count MBLs with 5-color flow cytometry: 90{\%} of CLL-like MBL but only 44.4{\%} atypical CLL and 66.7{\%} CD5 - MBL persisted over time. Population-screening CLL-like MBL had no relevant cell count change, and none developed an overt leukemia. In 50{\%} of the cases FISH showed CLL-related chromosomal abnormalities, including monoallelic or biallelic 13q deletions (43.8{\%}), trisomy 12 (1 case), and 17p deletions (2 cases). The analysis of the T-cell receptor β (TRBV) chains repertoire showed the presence of monoclonal T-cell clones, especially among CD4 highCD8 low, CD8 highCD4 low T cells. TRBV2 and TRBV8 were the most frequently expressed genes. This study indicates that (1) the risk of progression into CLL for low-count population-screening CLL-like MBL is exceedingly rare and definitely lower than that of clinical MBL and (2) chromosomal abnormalities occur early in the natural history and are possibly associated with the appearance of the typical phenotype.",
author = "Claudia Fazi and Lydia Scarf{\`o} and Lorenza Pecciarini and Francesca Cottini and Antonis Dagklis and Agnieszka Janus and Anna Talarico and Cristina Scielzo and Cinzia Sala and Daniela Toniolo and Federico Caligaris-Cappio and Paolo Ghia",
year = "2011",
month = "12",
day = "15",
doi = "10.1182/blood-2011-05-357251",
language = "English",
volume = "118",
pages = "6618--6625",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "25",

}

TY - JOUR

T1 - General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL

AU - Fazi, Claudia

AU - Scarfò, Lydia

AU - Pecciarini, Lorenza

AU - Cottini, Francesca

AU - Dagklis, Antonis

AU - Janus, Agnieszka

AU - Talarico, Anna

AU - Scielzo, Cristina

AU - Sala, Cinzia

AU - Toniolo, Daniela

AU - Caligaris-Cappio, Federico

AU - Ghia, Paolo

PY - 2011/12/15

Y1 - 2011/12/15

N2 - Monoclonal B-cell lymphocytosis (MBL) is classified as chronic lymphocytic leukemia (CLL)-like, atypical CLL, and CD5 -MBL. The number of B cells per microliter divides CLL-like MBL into MBL associated with lymphocytosis (usually detected in a clinical setting) and low-count MBL detected in the general population (usually identified during population screening). After a median follow-up of 34 months we reevaluated 76 low-count MBLs with 5-color flow cytometry: 90% of CLL-like MBL but only 44.4% atypical CLL and 66.7% CD5 - MBL persisted over time. Population-screening CLL-like MBL had no relevant cell count change, and none developed an overt leukemia. In 50% of the cases FISH showed CLL-related chromosomal abnormalities, including monoallelic or biallelic 13q deletions (43.8%), trisomy 12 (1 case), and 17p deletions (2 cases). The analysis of the T-cell receptor β (TRBV) chains repertoire showed the presence of monoclonal T-cell clones, especially among CD4 highCD8 low, CD8 highCD4 low T cells. TRBV2 and TRBV8 were the most frequently expressed genes. This study indicates that (1) the risk of progression into CLL for low-count population-screening CLL-like MBL is exceedingly rare and definitely lower than that of clinical MBL and (2) chromosomal abnormalities occur early in the natural history and are possibly associated with the appearance of the typical phenotype.

AB - Monoclonal B-cell lymphocytosis (MBL) is classified as chronic lymphocytic leukemia (CLL)-like, atypical CLL, and CD5 -MBL. The number of B cells per microliter divides CLL-like MBL into MBL associated with lymphocytosis (usually detected in a clinical setting) and low-count MBL detected in the general population (usually identified during population screening). After a median follow-up of 34 months we reevaluated 76 low-count MBLs with 5-color flow cytometry: 90% of CLL-like MBL but only 44.4% atypical CLL and 66.7% CD5 - MBL persisted over time. Population-screening CLL-like MBL had no relevant cell count change, and none developed an overt leukemia. In 50% of the cases FISH showed CLL-related chromosomal abnormalities, including monoallelic or biallelic 13q deletions (43.8%), trisomy 12 (1 case), and 17p deletions (2 cases). The analysis of the T-cell receptor β (TRBV) chains repertoire showed the presence of monoclonal T-cell clones, especially among CD4 highCD8 low, CD8 highCD4 low T cells. TRBV2 and TRBV8 were the most frequently expressed genes. This study indicates that (1) the risk of progression into CLL for low-count population-screening CLL-like MBL is exceedingly rare and definitely lower than that of clinical MBL and (2) chromosomal abnormalities occur early in the natural history and are possibly associated with the appearance of the typical phenotype.

UR - http://www.scopus.com/inward/record.url?scp=80054691036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054691036&partnerID=8YFLogxK

U2 - 10.1182/blood-2011-05-357251

DO - 10.1182/blood-2011-05-357251

M3 - Article

C2 - 21876118

AN - SCOPUS:80054691036

VL - 118

SP - 6618

EP - 6625

JO - Blood

JF - Blood

SN - 0006-4971

IS - 25

ER -